García AJ - Search Results

1

Hydrogel delivery of lysostaphin eliminates orthopedic implant infection by Staphylococcus aureus and supports fracture healing.

Johnson CT, Wroe JA, Agarwal R, Martin KE, Guldberg RE, Donlan RM, Westblade LF, García AJ. Johnson CT, et al. Among authors: garcia aj. Proc Natl Acad Sci U S A. 2018 May 29;115(22):E4960-E4969. doi: 10.1073/pnas.1801013115. Epub 2018 May 14. Proc Natl Acad Sci U S A. 2018. PMID: 29760099 Free PMC article.

2

Effects of medium perfusion rate on cell-seeded three-dimensional bone constructs in vitro.

Cartmell SH, Porter BD, García AJ, Guldberg RE. Cartmell SH, et al. Among authors: garcia aj. Tissue Eng. 2003 Dec;9(6):1197-203. doi: 10.1089/10763270360728107. Tissue Eng. 2003. PMID: 14670107

3

Addressing cell-sourcing limitations with gene therapy.

García AJ, Guldberg RE, Byers BA, Gersbach CA, Phillips JE. García AJ, et al. IEEE Eng Med Biol Mag. 2003 Sep-Oct;22(5):65-70. doi: 10.1109/memb.2003.1256274. IEEE Eng Med Biol Mag. 2003. PMID: 14699938 No abstract available.

4

Runx2/Cbfa1-genetically engineered skeletal myoblasts mineralize collagen scaffolds in vitro.

Gersbach CA, Byers BA, Pavlath GK, Guldberg RE, García AJ. Gersbach CA, et al. Among authors: garcia aj. Biotechnol Bioeng. 2004 Nov 5;88(3):369-78. doi: 10.1002/bit.20251. Biotechnol Bioeng. 2004. PMID: 15486943

5

Synergy between genetic and tissue engineering: Runx2 overexpression and in vitro construct development enhance in vivo mineralization.

Byers BA, Guldberg RE, García AJ. Byers BA, et al. Among authors: garcia aj. Tissue Eng. 2004 Nov-Dec;10(11-12):1757-66. doi: 10.1089/ten.2004.10.1757. Tissue Eng. 2004. PMID: 15684684

6

Effects of Runx2 genetic engineering and in vitro maturation of tissue-engineered constructs on the repair of critical size bone defects.

Byers BA, Guldberg RE, Hutmacher DW, García AJ. Byers BA, et al. Among authors: garcia aj. J Biomed Mater Res A. 2006 Mar 1;76(3):646-55. doi: 10.1002/jbm.a.30549. J Biomed Mater Res A. 2006. PMID: 16287095

7

Inducible regulation of Runx2-stimulated osteogenesis.

Gersbach CA, Le Doux JM, Guldberg RE, García AJ. Gersbach CA, et al. Among authors: garcia aj. Gene Ther. 2006 Jun;13(11):873-82. doi: 10.1038/sj.gt.3302725. Gene Ther. 2006. PMID: 16496016

8

Mineralization capacity of Runx2/Cbfa1-genetically engineered fibroblasts is scaffold dependent.

Phillips JE, Hutmacher DW, Guldberg RE, García AJ. Phillips JE, et al. Among authors: garcia aj. Biomaterials. 2006 Nov;27(32):5535-45. doi: 10.1016/j.biomaterials.2006.06.019. Epub 2006 Jul 20. Biomaterials. 2006. PMID: 16857257

9

In vitro and in vivo osteoblastic differentiation of BMP-2- and Runx2-engineered skeletal myoblasts.

Gersbach CA, Guldberg RE, García AJ. Gersbach CA, et al. Among authors: garcia aj. J Cell Biochem. 2007 Apr 1;100(5):1324-36. doi: 10.1002/jcb.21118. J Cell Biochem. 2007. PMID: 17131362

10

Dermal fibroblasts genetically modified to express Runx2/Cbfa1 as a mineralizing cell source for bone tissue engineering.

Phillips JE, Guldberg RE, García AJ. Phillips JE, et al. Among authors: garcia aj. Tissue Eng. 2007 Aug;13(8):2029-40. doi: 10.1089/ten.2006.0041. Tissue Eng. 2007. PMID: 17516856

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

491 results

Search Page